Prepping Biosimilars

Brochures and specifications | 2014 | Agilent TechnologiesInstrumentation
Sample Preparation, Consumables
Industries
Pharma & Biopharma, Clinical Research
Manufacturer
Agilent Technologies
Key words
Downloadable PDF for viewing
 

Similar PDF

Toggle
Application Note Biopharma/Pharma Automated Switching between Peptide and Glycan Mapping with the Agilent 1290 Infinity II LC System Increased productivity and flexibility in the characterization of monoclonal antibodies Authors Gerd Vanhoenacker, Aurélie Terrier, Gianni Vandenborre, Pat Sandra, and Koen Sandra…
Key words
glycan, glycanpeptide, peptideoriginator, originatormapping, mappingtrastuzumab, trastuzumabcounts, countsbiosimilar, biosimilaracquisition, acquisitionadvancebio, advancebiounits, unitsresponse, responsefld, fldinstantpc, instantpccho, chorituximab
Agilent Biocolumns Critical Quality Attributes Application Compendium Contents Introduction 05 1 Titer determination 07 1.1 1.2 1.3 1.4 1.5 Background Getting Started How to Guide - Affinity Chromatography for Titer Determination Featured Application Notes Cell Clone Selection Using the Agilent…
Key words
return, returnsection, sectioncontents, contentsmau, mauadvancebio, advancebiopeptide, peptidemin, minglycan, glycanprotein, proteinbiosimilar, biosimilaramino, aminoinnovator, innovatormapping, mappingcolumn, columnagilent
Biopharmaceutical Characterisation Compendium A complete toolbox of techniques, workflows and technologies for comprehensive biopharmaceutical characterisation Please click the circles to navigate INTRODUCTION AGGREGATE ANALYSIS CHARGE VARIANT ANALYSIS PEPTIDE MAPPING GLYCANS INTACT AND SUBUNIT ANALYSIS INTRODUCTION The resources collected in this…
Key words
mapping, mappingpeptide, peptideaggregate, aggregatevariant, variantglycans, glycanssponsored, sponsoredcharge, chargesubunit, subunitanalysis, analysisintact, intactglycan, glycanprotein, proteinmonoclonal, monoclonalvanquish, vanquishlinks
Identifying Monoclonal Antibody Mutation Sites Using the Agilent 1290 Infinity II 2D-LC Solution with Q-TOF LC/MS Application Note Biopharmaceuticals and Biosimilars Authors Abstract Koen Sandra, Gerd Vanhoenacker, In recent years, 2D-LC has been highly promising for the detailed characterization Mieke…
Key words
infliximab, infliximabbiosimilar, biosimilaroriginator, originatorrplc, rplcslslspgk, slslspgkslslspg, slslspgydywgqgttltvssastk, ydywgqgttltvssastkcandidate, candidatenyygstydywgqgttltvssastk, nyygstydywgqgttltvssastkbiosimilars, biosimilarspeptide, peptidedimension, dimensiondimensional, dimensionalmutations, mutationsheavy
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o., all rights reserved.